Copyright: ©Author(s) 2026.
World J Psychiatry. Apr 19, 2026; 16(4): 113329
Published online Apr 19, 2026. doi: 10.5498/wjp.v16.i4.113329
Published online Apr 19, 2026. doi: 10.5498/wjp.v16.i4.113329
Table 4 Univariable examination of adverse pregnancy outcomes among pregnant women
| Indicators | Adverse outcome group (n = 29) | Favorable outcome group (n = 134) | χ2 | P value |
| Age (years) | 0.409 | 0.522 | ||
| < 30 (n = 93) | 15 (51.72) | 78 (58.21) | ||
| ≥ 30 (n = 70) | 14 (48.28) | 56 (41.79) | ||
| Gravidity (times) | 9.766 | 0.002 | ||
| < 3 (n = 108) | 12 (41.38) | 96 (71.64) | ||
| ≥ 3 (n = 55) | 17 (58.62) | 38 (28.36) | ||
| Gestational age at delivery (weeks) | 1.754 | 0.185 | ||
| < 39 (n = 80) | 11 (37.93) | 69 (51.49) | ||
| ≥ 39 (n = 83) | 18 (62.07) | 65 (48.51) | ||
| Neonatal birth weight (g) | 0.891 | 0.345 | ||
| < 3150 (n = 86) | 13 (44.83) | 73 (54.48) | ||
| ≥ 3150 (n = 77) | 16 (55.17) | 61 (45.52) | ||
| Newborn feeding practices | 0.585 | 0.746 | ||
| Breast milk (n = 85) | 15 (51.72) | 70 (52.24) | ||
| Milk powder (n = 35) | 5 (17.24) | 30 (22.39) | ||
| Mixed (n = 43) | 9 (31.03) | 34 (25.37) | ||
| PPD | 11.380 | < 0.001 | ||
| No (n = 80) | 6 (20.69) | 74 (55.22) | ||
| Yes (n = 83) | 23 (79.31) | 60 (44.78) | ||
| TSH (mIU/L) | 13.210 | < 0.001 | ||
| < 3 (n = 89) | 7 (24.14) | 82 (61.19) | ||
| ≥ 3 (n = 74) | 22 (75.86) | 52 (38.81) | ||
| TPOAb (U/mL) | 7.284 | 0.007 | ||
| < 7 (n = 82) | 8 (27.59) | 74 (55.22) | ||
| ≥ 7 (n = 81) | 21 (72.41) | 60 (44.78) |
- Citation: Chen JJ, Chen XJ, She QM, Ouyang S. Maternal thyroid-stimulating hormone and thyroid peroxidase antibody levels: Associations with postpartum depression and impacts on adverse pregnancy outcomes. World J Psychiatry 2026; 16(4): 113329
- URL: https://www.wjgnet.com/2220-3206/full/v16/i4/113329.htm
- DOI: https://dx.doi.org/10.5498/wjp.v16.i4.113329